|
|
.
ICD-10 (CM) Code and Descriptor
|
D49.7 |
Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
|
D497 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 43.79%
|
20.37%
|
11.96%
|
6.91%
|
4.95%
|
3.51%
|
2.46%
|
1.89%
|
1.11%
|
0.84%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D49.7*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,851
|
1,859
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,555
|
1,561
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
1,269
|
1,277
|
|
84443
|
ASSAY THYROID STIM HORMONE |
815
|
819
|
|
84439
|
ASSAY OF FREE THYROXINE |
704
|
704
|
|
82533
|
TOTAL CORTISOL |
613
|
640
|
|
A9585
|
GADOBUTROL INJECTION |
554
|
40,423
|
|
97110
|
THERAPEUTIC EXERCISES |
544
|
918
|
|
82565
|
ASSAY OF CREATININE |
535
|
536
|
|
G1004
|
CDSM NDSC |
528
|
582
|
|
80053
|
COMPREHEN METABOLIC PANEL |
510
|
510
|
|
84146
|
ASSAY OF PROLACTIN |
508
|
513
|
|
97530
|
THERAPEUTIC ACTIVITIES |
477
|
825
|
|
80048
|
METABOLIC PANEL TOTAL CA |
398
|
398
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
384
|
384
|
|
A9577
|
INJ MULTIHANCE |
383
|
5,738
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
378
|
56,742
|
|
82024
|
ASSAY OF ACTH |
344
|
344
|
|
84305
|
ASSAY OF SOMATOMEDIN |
334
|
334
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
302
|
303
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D49.7 related to the following DRG Codes:
643-645
|
